Skip to main content
Have a personal or library account? Click to login
WHF Recommendations for the Use of Echocardiography in Chagas Disease Cover

WHF Recommendations for the Use of Echocardiography in Chagas Disease

Open Access
|Jun 2023

References

  1. Echeverría LE, Marcus R, Novick G, Sosa-Estani S, Ralston K, Zaidel EJ, et al. WHF IASC Roadmap on Chagas Disease. Glob Heart. 2020; 15(1): 26. DOI: 10.5334/gh.484
  2. Ribeiro AL, Marcolino MS, Prineas RJ, Lima-Costa MF. Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging. J Am Heart Assoc. 2014; 3(1): e000632. DOI: 10.1161/JAHA.113.000632
  3. Acquatella H, Asch FM, Barbosa MM, Barros M, Bern C, Cavalcante JL, et al. Recommendations for Multimodality Cardiac Imaging in Patients with Chagas Disease: A Report from the American Society of Echocardiography in Collaboration With the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology (DIC-SBC). J Am Soc Echocardiogr. 2018; 31(1): 325. DOI: 10.1016/j.echo.2017.10.019
  4. Yadav H, Shah D, Sayed S, Horton S, Schroeder LF. Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys. Lancet Glob Health. 2021; 9(11): e1553e60. DOI: 10.1016/S2214-109X(21)00442-3
  5. Norman D, Olaf H. An experimental application of the DELPHI method to the use of experts. Manag Sci. 1963; 9(3): 45867. DOI: 10.1287/mnsc.9.3.458
  6. Patel MR, Spertus JA, Brindis RG, Hendel RC, Douglas PS, Peterson ED, et al. ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. J Am Coll Cardiol. 2005; 46(8): 160613. DOI: 10.1016/j.jacc.2005.08.030
  7. Rassi A, Jr, Rassi A, Marin-Neto JA. Chagas disease. The Lancet. 2010; 375(9723): 1388402. DOI: 10.1016/S0140-6736(10)60061-X
  8. Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverría LE, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation. 2018; 138(12): e169e209. DOI: 10.1161/CIR.0000000000000599
  9. Navarro M, Navaza B, Guionnet A, López-Vélez R. Chagas disease in Spain: need for further public health measures. PLoS Negl Trop Dis. 2012; 6(12): e1962. DOI: 10.1371/journal.pntd.0001962
  10. Lima NA, Martin DT, de Castro RL, Ladzinski A, Ring A, Vos D, et al. Hospitalization for Chagas Heart Disease in the United States From 2002 to 2017. JAMA Netw Open. 2021; 4(10): e2129959. DOI: 10.1001/jamanetworkopen.2021.29959
  11. Gascón J, Albajar P, Cañas E, Flores M, Gómez i Prat J, Herrera RN, et al. Diagnosis, management and treatment of chronic Chagas heart disease in areas where Trypanosoma cruzi infection is not endemic. Rev Esp Cardiol. 2007; 60(3): 28593.DOI: 10.1157/13100280
  12. Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007; 115(9): 11018. DOI: 10.1161/CIRCULATIONAHA.106.627265
  13. Ortiz JV, Pereira BVM, Couceiro KDN, Silva MRHD, Doria SS, Silva PRLD, et al. Cardiac Evaluation in the Acute Phase of Chagas’ Disease with Post-Treatment Evolution in Patients Attended in the State of Amazonas, Brazil. Arq Bras Cardiol. 2019; 112(3): 2406. DOI: 10.5935/abc.20190007
  14. Gray EB, La Hoz RM, Green JS, Vikram HR, Benedict T, Rivera H, et al. Reactivation of Chagas disease among heart transplant recipients in the United States, 2012–2016. Transpl Infect Dis. 2018; 20(6): e12996. DOI: 10.1111/tid.12996
  15. Bacal F, Silva CP, Pires PV, Mangini S, Fiorelli AI, Stolf NG and Bocchi EA. Transplantation for Chagas’ disease: an overview of immunosuppression and reactivation in the last two decades. Clin Transplant. 2010; 24(2): E29E34. DOI: 10.1111/j.1399-0012.2009.01202.x
  16. Morillo CA, Waskin H, Sosa-Estani S, Del Carmen Bangher M, Cuneo C, Milesi R, et al. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. J Am Coll Cardiol. 2017; 69(8): 93947. DOI: 10.1016/j.jacc.2016.12.023
  17. Chadalawada S, Sillau S, Archuleta S, Mundo W, Bandali M, Parra-Henao G, et al. Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020; 3(8): e2015072. DOI: 10.1001/jamanetworkopen.2020.15072
  18. Andrade JP, Marin Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas’ heart disease: executive summary. Arq Bras Cardiol. 2011; 96(6): 43442. DOI: 10.1590/S0066-782X2011000600002
  19. Tazar J, Arce Rojas N, Barbosa M. Alteraciones ecocardiográficas precoces en la enfermedad de Chagas crónica sin patología demostrada. Insuficiencia cardíaca. 2017; 12(3): 106110.
  20. Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN, Investigators S. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992; 327(10): 68591. DOI: 10.1056/NEJM199209033271003
  21. Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006; 355(8): 799808. DOI: 10.1056/NEJMoa053241
  22. Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007; 115(9): 112431. DOI: 10.1161/CIRCULATIONAHA.106.627323
  23. Fernandez AB, Nunes MC, Clark EH, Samuels A, Menacho S, Gomez J, et al. Electrocardiographic and echocardiographic abnormalities in Chagas disease: Findings in residents of rural Bolivian communities hyperendemic for Chagas disease. Glob Heart. 2015; 10(3): 15966. DOI: 10.1016/j.gheart.2015.07.004
  24. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1): 139.e14. DOI: 10.1016/j.echo.2014.10.003
  25. Chamsi-Pasha MA, Sengupta PP, Zoghbi WA. Handheld Echocardiography: Current State and Future Perspectives. Circulation. 2017; 136(22): 217888. DOI: 10.1161/CIRCULATIONAHA.117.026622
  26. Becker DM, Tafoya CA, Becker SL, Kruger GH, Tafoya MJ, Becker TK. The use of portable ultrasound devices in low- and middle-income countries: a systematic review of the literature. Trop Med Int Health. 2016; 21(3): 294311. DOI: 10.1111/tmi.12657
  27. Parada H, Carrasco HA, Añez N, Fuenmayor C, Inglessis I. Cardiac involvement is a constant finding in acute Chagas‘ disease: a clinical, parasitological and histopathological study. Int J Cardiol. 1997; 60(1): 4954. DOI: 10.1016/S0167-5273(97)02952-5
  28. Viotti RJ, Vigliano C, Laucella S, Lococo B, Petti M, Bertocchi G, et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart. 2004; 90(6): 65560. DOI: 10.1136/hrt.2003.018960
  29. Dias JC, Ramos AN, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. 2 nd Brazilian Consensus on Chagas Disease, 2015. Rev Soc Bras Med Trop. 2016; 49Suppl 1(Suppl 1): 360. DOI: 10.1590/0037-8682-0504-2016
  30. Rossi MA. Fibrosis and inflammatory cells in human chronic chagasic myocarditis: scanning electron microscopy and immunohistochemical observations. Int J Cardiol. 1998; 66(2): 18394. DOI: 10.1016/S0167-5273(98)00208-3
  31. Barros, MV, Leren, IS, Edvardsen, T, Haugaa, KH, Carmo, AA, Lage, TA, et al. Mechanical Dispersion Assessed by Strain Echocardiography Is Associated with Malignant Arrhythmias in Chagas Cardiomyopathy. J Am Soc Echocardiogr. 2016; 29(4): 36874. DOI: 10.1016/j.echo.2015.12.008
  32. García-Álvarez A, Sitges M, Regueiro A, Poyatos S, Jesus Pinazo M, Posada E, et al. Myocardial deformation analysis in Chagas heart disease with the use of speckle tracking echocardiography. J Card Fail. 2011; 17(12): 102834. DOI: 10.1016/j.cardfail.2011.08.007
  33. Gomes VA, Alves GF, Hadlich M, Azevedo CF, Pereira IM, Santos CR, et al. Analysis of Regional Left Ventricular Strain in Patients with Chagas Disease and Normal Left Ventricular Systolic Function. J Am Soc Echocardiogr. 2016; 29(7): 67988. DOI: 10.1016/j.echo.2016.03.007
  34. Picard MH, Popp RL, Weyman AE. Assessment of left ventricular function by echocardiography: a technique in evolution. J Am Soc Echocardiogr. 2008; 21(1): 1421. DOI: 10.1016/j.echo.2007.11.007
  35. Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr. 2012; 25(1): 346. DOI: 10.1016/j.echo.2011.11.010
  36. Nascimento CA, Gomes VA, Silva SK, Santos CR, Chambela MC, Madeira FS, et al. Left atrial and left ventricular diastolic function in chronic Chagas disease. J Am Soc Echocardiogr. 2013; 26(12): 142433. DOI: 10.1016/j.echo.2013.08.018
  37. Menezes Junior ADS, Lopes CC, Cavalcante PF, Martins E. Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis. Braz J Cardiovasc Surg. 2018; 33(1): 828. DOI: 10.21470/1678-9741-2017-0134
  38. Martinelli Filho M, de Lima Peixoto G, de Siqueira SF, Martins SA, Nishioka SA, Pedrosa AA, et al. A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy. Europace. 2018; 20(11): 18131818. DOI: 10.1093/europace/eux375
  39. Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL, Cardiology CoCDotISo. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013; 62(9): 76776. DOI: 10.1016/j.jacc.2013.05.046
  40. Oliveira JS, Mello De Oliveira JA, Frederigue U, Lima Filho EC. Apical aneurysm of Chagas’s heart disease. Br Heart J. 1981; 46(4): 4327. DOI: 10.1136/hrt.46.4.432
  41. Nunes MoC, Barbosa MM, Rocha MO. Peculiar aspects of cardiogenic embolism in patients with Chagas’ cardiomyopathy: a transthoracic and transesophageal echocardiographic study. J Am Soc Echocardiogr. 2005; 18(7): 7617. DOI: 10.1016/j.echo.2005.01.026
  42. Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018; 19(4): 45960n. DOI: 10.1093/ehjci/jex154
  43. Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol. 2012; 9(10): 57689. DOI: 10.1038/nrcardio.2012.109
  44. Garcia-Alvarez A, Sitges M, Pinazo MJ, Regueiro-Cueva A, Posada E, Poyatos S, et al. Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS Negl Trop Dis. 2010; 4(9): e826. DOI: 10.1371/journal.pntd.0000826
  45. Pazin-Filho A, Romano MM, Gomes Furtado R, de Almeida Filho OC, Schmidt A, Marin-Neto JA, et al. Left ventricular global performance and diastolic function in indeterminate and cardiac forms of Chagas’ disease. J Am Soc Echocardiogr. 2007; 20(12): 133843. DOI: 10.1016/j.echo.2007.04.029
  46. Barbosa MM, Costa Rocha MO, Vidigal DF, Bicalho Carneiro ReC, Araújo RD, Palma MC, et al. Early detection of left ventricular contractility abnormalities by two-dimensional speckle tracking strain in Chagas’ disease. Echocardiography. 2014; 31(5): 62330. DOI: 10.1111/echo.12426
  47. Nunes MC, Reis RC, Colosimo EA, Ribeiro AL, Barbosa FB, da Silva JL, et al. Risk estimation approach in Chagas disease is still needed. Int J Cardiol. 2011; 147(2): 2946. DOI: 10.1016/j.ijcard.2010.12.044
  48. Nunes MP, Colosimo EA, Reis RC, Barbosa MM, da Silva JL, Barbosa F, et al. Different prognostic impact of the tissue Doppler-derived E/e’ ratio on mortality in Chagas cardiomyopathy patients with heart failure. J Heart Lung Transplant. 2012; 31(6): 63441. DOI: 10.1016/j.healun.2012.01.865
  49. Fragata CaS, Matsumoto AY, Ramires FJ, Fernandes F, Buck PeC, Salemi VM, et al. Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy. Arq Bras Cardiol. 2015; 105(1): 2836. DOI: 10.5935/abc.20150045
  50. Nunes MC, Barbosa MM, Ribeiro AL, Colosimo EA, Rocha MO. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J Am Soc Echocardiogr. 2009; 22(1): 828. DOI: 10.1016/j.echo.2008.11.015
  51. Mancuso FJ, Almeida DR, Moisés VA, Oliveira WA, Mello ES, Poyares D, et al. Left atrial dysfunction in chagas cardiomyopathy is more severe than in idiopathic dilated cardiomyopathy: a study with real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2011; 24(5): 52632. DOI: 10.1016/j.echo.2011.01.013
  52. Barbosa MM, Rocha MO, Botoni FA, Ribeiro AL, Nunes MC. Is atrial function in Chagas dilated cardiomyopathy more impaired than in idiopathic dilated cardiomyopathy? Eur J Echocardiogr. 2011; 12(9): 6437. DOI: 10.1093/ejechocard/jer096
  53. Barros MV, Machado FS, Ribeiro AL, Da Costa Rocha MO. Detection of early right ventricular dysfunction in Chagas’ disease using Doppler tissue imaging. J Am Soc Echocardiogr. 2002; 15(10 Pt 2): 1197201. DOI: 10.1067/mje.2002.122966
  54. Furtado RG, Frota DoC, Silva JB, Romano MM, Almeida Filho OC, Schmidt A, et al. Right ventricular Doppler echocardiographic study of indeterminate form of chagas disease. Arq Bras Cardiol. 2015; 104(3): 20917. DOI: 10.5935/abc.20140197
  55. Nunes MoC, Barbosa MeM, Brum VA, Rocha MO. Morphofunctional characteristics of the right ventricle in Chagas’ dilated cardiomyopathy. Int J Cardiol. 2004; 94(1): 7985. DOI: 10.1016/j.ijcard.2003.05.003
  56. Nunes MoC, Rocha MO, Ribeiro AL, Colosimo EA, Rezende RA, Carmo GA, et al. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas’ cardiomyopathy. Int J Cardiol. 2008; 127(3): 3729. DOI: 10.1016/j.ijcard.2007.06.012
  57. Romano MMD, Moreira HT, Schmidt A, Maciel BC, Marin-Neto JA. Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy. Biomed Res Int. 2017; 2017: 3820191. DOI: 10.1155/2017/3820191
  58. Nunes MC, Carmo AA, Rocha MO, Ribeiro AL. Mortality prediction in Chagas heart disease. Expert Rev Cardiovasc Ther. 2012; 10(9): 117384. DOI: 10.1586/erc.12.111
  59. Nunes MoC, Beloti FR, Lima MM, Barbosa MM, Pinto Filho MM, de Barros MV, et al. Functional capacity and right ventricular function in patients with Chagas heart disease. Eur J Echocardiogr. 2010; 11(7): 5905. DOI: 10.1093/ejechocard/jeq022
  60. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561632. DOI: 10.1093/eurheartj/ehab395
  61. de Almeida EA, Camargo LF, Lopes MA, de Castro Neto P, Salemi VM, Libermann A, et al. Mitral valve prolapse in chronic Chagas patients. Echocardiographic study. Arq Bras Cardiol. 1986; 47(3): 20710.
  62. Ramos JM, Torrús D, Amador C, Jover F, Pérez-Chacón F, Ponce Y, et al. Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain. Pathog Glob Health. 2012; 106(6): 3405. DOI: 10.1179/2047773212Y.0000000039
  63. Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A, Rosas F, et al. Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy. N Engl J Med. 2015; 373(14): 1295306. DOI: 10.1056/NEJMoa1507574
  64. García-Chamorro LG, Zaidel EJ, Gheco L, Oliva MA, de-la-Vega A, Orosco A, et al. First appropriate implantable defibrillator shocks in patients with Chagasic heart disease. Arch Cardiol Mex. 2022; 92(3): 3428. DOI: 10.24875/ACME.M22000326
  65. Xavier SS, Sousa AS, Mallet AR, Hasslocher-Moreno A. Progressão da lesão miocardica na doença de Chagas: um estudo ecocardiográfico. Arq Bras Cardiol. 2004; 83(Suppl III): 127.
  66. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599726. DOI: 10.1093/eurheartj/ehab368
  67. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol. 2005; 46(8): 15538. DOI: 10.1016/j.jacc.2005.06.067
  68. Romero J, Velasco A, Pisani CF, Alviz I, Briceno D, Díaz JC, et al. Advanced Therapies for Ventricular Arrhythmias in Patients With Chagasic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021; 77(9): 122542. DOI: 10.1016/j.jacc.2020.12.056
  69. Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D, et al. Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease. Arq Bras Cardiol. 2012; 98(5): 42130. DOI: 10.1590/S0066-782X2012005000031
  70. Senra T, Ianni BM, Costa ACP, Mady C, Martinelli-Filho M, Kalil-Filho R, et al. Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy. J Am Coll Cardiol. 2018; 72(21): 257787. DOI: 10.1016/j.jacc.2018.08.2195
  71. Pacheco AB, Melo RJ, Rochitte CE. Cardiac Magnetic Resonance in the Assessment of Chagas Disease and its Complications. Int. J. Cardiovasc. Sci. 2020; 33(6): 70512. DOI: 10.36660/ijcs.20200250
  72. Antonio M-NJ, Romano MMD, Maciel BC. Cardiac Imaging in Latin America: Chagas Heart Disease. CurrCardiovasc Imaging Rep. 2015; 8(9). DOI: 10.1007/s12410-015-9324-2
  73. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007; 115(9): 110923. DOI: 10.1161/CIRCULATIONAHA.106.624296
  74. Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simões MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med. 2011; 52(4): 50410. DOI: 10.2967/jnumed.110.082032
  75. Lemos de Oliveira LF, Thackeray JT, Marin Neto JA, Dias Romano MM, Vieira de Carvalho EE, Mejia J, et al. Regional Myocardial Perfusion Disturbance in Experimental Chronic Chagas Cardiomyopathy. J Nucl Med. 2018; 59(9): 14306. DOI: 10.2967/jnumed.117.205450
  76. Simoes MV, Tanaka DM, Marin-Neto JA. Nuclear Medicine Methods for Assessment of Chronic Chagas Heart Disease. Int. J. Cardiovasc. Sci. 2020; 33(6): 6869. DOI: 10.36660/ijcs.20200153
DOI: https://doi.org/10.5334/gh.1207 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 9, 2023
Accepted on: May 2, 2023
Published on: Jun 8, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Kate Ralston, Ezequiel Zaidel, Harry Acquatella, Marcia Melo Barbosa, Jagat Narula, Yu Nakagama, Gustavo Restrepo Molina, Karen Sliwa, Jose Luis Zamorano, Fausto J. Pinto, Daniel Jose Piñeiro, Mariana Corneli, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.